Selene Therapeutics

Epilepsy Therapy

Health Tech & Life Sciences

Active

Seed Founded 2020

Website ↗ LinkedIn

Total raised

—

Last: Seed 2024-06

Stage

Seed

Founded

2020

Headcount

Sector

Health Tech & Life Sciences

About

Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by regulating the neuronal activity set point by reducing the neuronal mean firing rate. Selene aims to develop small molecules for inhibitors of dihydroorotate dehydrogenase, a mitochondrial enzyme located on the inner mitochondrial membrane that participates in several key cellular homeostatic processes. The company is part of the FuturX biotech incubator in Ness Ziona.

Funding history · 2 rounds · — total

2024-06

Seed Undisclosed

2020-10

Seed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsMolecules

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Name	Selene Therapeutics
Slug	selene-therapeutics
Type	Israeli Startup
Founded	2020
HQ city
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	0
Last round	Seed (2024-06)
Website	https://www.futurx.co.il/cgi-sys/suspendedpage.cgi
Israeli Companies Registrar	516254471

Date	Round	Amount	Lead investors	All investors	Valuation
2020-10	Seed	Undisclosed		RMGP Biopharma Investment Fund, FutuRx
2024-06	Seed	Undisclosed		Israel Innovation Authority

Name	Role	LinkedIn
Inna Slutsky
Neta Pessah

Selene Therapeutics

About

Funding history · 2 rounds · — total

Sectors & technology

Tags